rheumatoid arthritis, RA
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Those who fulfill all of the following criteria are eligible for enrollment: RA population: ? 18-75 years of age (including borderline values) and gender; ? All meet the 1987 American College of Rheumatology classification criteria or the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria; ? Voluntarily participated in the study and signed a written informed consent. Non-RA population: ? 18-75 years of age (including borderline values) and gender; ? Not meeting the 1987 American College of Rheumatology classification criteria or the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria; ?Voluntarily participated in this study and signed a written informed consent.
Exclusion criteria
Exclusion criteria: Exclusion was required if any of the following criteria were met: ? Patients who have participated in a non-interventional clinical trial within 3 months prior to screening; ? Those with a history of any of the following diseases: a. Those with a history of malignancy; b. Those with a history of hepatitis B or C; c. Those with a history of acute infections within 1 month prior to screening: e.g., colds, fevers, new crown infections, pneumonia, etc.; d. Those with a history of chronic inflammatory diseases: e.g., nephritis, pancreatitis, etc.; e. Those with a history of diabetes. ? Other conditions that the investigator considers unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rheumatoid Factor(RF);anti-cyclic peptide containing citrulline(CCP); | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythrocyte Sedimentation Rate(ESR);C reactive protein(CRP); | — |
Countries
China
Contacts
Zhongda Hospital Southeast University